Life Saving Leave Act

Hozzl · 2024-02-01T08:30:26Z

Explore the details of House Bill 3024 Life Saving Leave Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Labor and Employment. Stay informed on legislative developments.

2/1/2024, 8:30 AM

Summary of Bill HR 3024

Bill 118 hr 3024, also known as the Life Saving Leave Act, is a piece of legislation currently being considered by the US Congress. The purpose of this bill is to provide employees with the ability to take leave from work in order to donate bone marrow or organs for transplant purposes.

Under the Life Saving Leave Act, eligible employees would be able to take up to 30 days of unpaid leave in a 12-month period for the purpose of donating bone marrow or organs. This leave would be in addition to any other leave that the employee is entitled to under the Family and Medical Leave Act (FMLA).

In order to be eligible for leave under this bill, employees must provide their employer with reasonable advance notice of their intention to donate bone marrow or organs. Employers would be prohibited from retaliating against employees who request leave under this bill. The Life Saving Leave Act aims to encourage and support individuals who wish to donate bone marrow or organs for transplant purposes by providing them with the necessary time off from work to do so. This bill is seen as a way to potentially save lives and improve the health outcomes of those in need of transplants. Overall, the Life Saving Leave Act is a bipartisan effort to support and promote organ and bone marrow donation by providing employees with the necessary leave to do so. It is currently being reviewed by Congress and may be voted on in the near future.

Congressional Summary of HR 3024

Life Saving Leave Act

This bill expands employee medical leave to provide additional time for bone marrow or blood stem cell donations.

Specifically, the bill expands leave under the Family and Medical Leave Act of 1993 (FMLA) to provide up to 40 hours of leave every 12 months for related predonation, donation, and postdonation activities. Under the bill, leave may be taken intermittently or on a reduced leave schedule. An employee has the option to substitute accrued paid vacation, personal, or sick leave for the unpaid FMLA time.

The bill requires an employee to make a reasonable effort to schedule treatments for when the treatment would not unduly disrupt the employer's activities.

Eligible employees may use this leave regardless of the employee's length of employment or the size of the employer.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 3024

Bill HR 3024 is currently in the status of Bill Introduced since April 28, 2023. Bill HR 3024 was introduced during Congress 118 and was introduced to the House on April 28, 2023. Bill HR 3024's most recent activity was Referred to the Committee on Education and the Workforce, and in addition to the Committees on Oversight and Accountability, and House Administration, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of April 28, 2023